BioWorld MedTech

May 18, 2012

EuroPCR 2012: Unnerving developments in renal denervation: Product pipeline packed as competition heats up

PARIS While cardiologists play coy about their interest in taking up the new procedure for renal denervation, industry is running at full steam toward what can only be described a massive market opportunity. Read More

GE, Philips take center stage in FCC MBANs discussion

Cardiologists conflicted over role in kidney intervention

Washington roundup: Speaker proposes cost as a criterion for trial coverage

Deals roundup: CryoLife completes Hemosphere acquisition for more than $17M

Financings roundup: Zyga Technology raises $25M in a Series C funding round

Court report: Medtronic claims government has closed Infuse investigation

EuroPCR notebook: Medtronic study: CoreValve benefits men, women similarly

Agreements/contracts: 3M to open healthcare dictionary to DoD, VA

Product Briefs

People in the News

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...